Here the Beckley Foundation attempts to summarize the many studies that are happening around the world using psychedelics with human participants for both clinical and research purposes.

Worldwide Psychedelic Research

Psychedelics can trigger insight, but behavior change takes time and a changed environment to take root. Through personal stories, participants will explore the concept and process of change in psychedelic therapy. How do psychedelics redefine medicine and science, and how can we effectively reintegrate them into contemporary society? Speakers: Neal Goldsmith Psychotherapist and Counselor Rick [...]

USA Today 29.9.2011 – Coverage of a Beckley Foundation project In new research that will almost certainly create controversy, scientists working with the hallucinogen psilocybin — the active ingredient found in “magic mushrooms” — have found that a single dose of the drug prompted an enduring but positive personality change in almost 60 percent of [...]

A documentary film crew have been chronicling the research of a Canadian doctor and author whose travels through the Amazon have taught him about psychotropic medicines. Doctor Gabor Maté first learnt about the healing potential of Ayahuasca at a clinic in Peru, and was startled to learn that the rates of success of treatment for [...]

This is a brilliant new study from the team at Johns Hopkins University.  The Beckley Foundation is currently collaborating on another study with the team from Johns Hopkins, led by Professor Roland Griffiths, researching the effects of psilocybin as an aid to psychotherapy for treating nicotine addiction. The results so far have been extremely promising. [...]

Bureau for International Narcotics and Law Enforcement Affairs. Chemicals play two essential roles in the production of illegal drugs: as starting chemical inputs for the production of synthetic drugs such as methamphetamine and MDMA (3,4-methylenedioxmethamphetamine more commonly known under the name of ecstasy); and as refining agents and solvents for processing plant-based materials such as [...]

Serotonergic hallucinogens —such as LSD, mescaline, and psilocybin— produce a bewildering variety of visual phenomena [1–7]. Visual changes include altered form and depth perception, prolonged afterimages, motion-processing impairments, vivid pseudo-hallucinations, and, only very rarely, actual hallucinations in which insight into the non-veridical nature of the experience is impaired [8–17]. Pseudo-hallucinations can occur both with the [...]

Horizon clip A study of MDMA-cannabis interactions from Dumont and colleagues: G J Dumont1, C Kramers2, F C Sweep3, D J Touw4, J G van Hasselt5, M de Kam5, J M van Gerven5, J K Buitelaar1 and R J Verkes1 1Department of Psychiatry, Donders Institute for Brain, Cognition, and Behavior, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands 2Department of Pharmacology–Toxicology, Radboud University Nijmegen [...]